Efficacy and safety of low-intensity chemotherapy combined with immunotherapy in elderly patients with locally advanced and metastatic non–small cell lung cancer: a retrospective analysis
Abstract For advanced non-small cell lung cancer (NSCLC) lacking driver mutations, immunotherapy combined with chemotherapy is a standard treatment; however, elderly patients frequently exhibit poor tolerance to standard chemotherapy and derive limited benefit from immunotherapy alone. Thus, this re...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2026-04-01
|
| Serier: | BMC Cancer |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12885-026-15943-1 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
